Only one Canadian has ever received the Nobel Prize for medicine, in 1923. But Canadian discoveries have been essential to stem cell research, gene sequencing and treatments for cancer.
Academic rigour, journalistic flair
Articles on Genomics
Displaying 121 - 140 of 175 articles
Star Wars: The Last Jedi leaves many questions about the saga in a galaxy far, far away unanswered. Fortunately, biology may offer a insights on the Force, midi-chlorians, clones, and Rey’s lineage.
The rapid growth of genetic testing and data-gathering could revolutionize health and medicine if governments work to protect people against privacy and societal risks.
Genome sequencing is transforming the way we diagnose disease. But lack of diversity in genomic data means only some Canadians will benefit from this revolutionary technology.
Treating video like a mutating gene could improve surveillance software.
A new gene editing experiment explores human development. With this comes new ethical questions: How do scientists acquire embryos and how are their projects approved?
Colin Smith became the first person to donate his genomic data to the Personal Genome Project UK under ‘open consent’ – waiving rights to anonymity.
Some animals seem to have missing genes – but the reality is a lot more intriguing.
Ability expectations are what people rely upon as they seek out productive and satisfying lives. They need to be a key part of the debate over gene-editing and other major scientific breakthroughs.
Once online, our healthcare data could be used for research long after we’re gone.
A team in the U.S. is said to have safely and effectively altered human embryos. The news is a reminder that citizens must be consulted on developments potentially affecting the future of the species.
Research laboratories are dominated by men, and that’s not only bad for lab culture, it can be dangerous for science.
A diagnosis of glioblastoma did not keep John McCain from the Capitol to cast a crucial vote that could end Obamacare. His actions are a reminder that stats are one thing but human beings, another.
A freedom of information request reveals that Google wants its AI company DeepMind to get involved in the 100,000 Genomes Project.
A test of all your genes for disease risk is not yet the precision diagnostic and treatment tool we hope it will one day be.
The advent of genetic technologies has been reducing the time and cost attached to diagnosing rare genetic diseases.
A new code of conduct for researchers has been developed by the San peoples of southern Africa.
Although genomics research has the potential to revolutionize medicine, it has limitations. It may not do much to prevent many of the leading causes of death.
Not only are tumors are different from one another, but there can even be genetic differences within a single tumor.
New regulations for research with human blood and tissue try to balance scientific progress with patient privacy.
Top contributors
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Emeritus Robert Reford Professor and Professor of Medicine, McGill University
-
Executive Director, Melbourne Genomics Health Alliance, Walter and Eliza Hall Institute
-
Thomas Merritt is a Friend of The Conversation.
Professor, Chemistry and Biochemistry, Laurentian University
-
Vanier Scholar and Ph.D. Candidate in Microbiology and Immunology, Dalhousie University
-
Mathematics Lecturer and Ancient DNA Researcher, University of Adelaide
-
Director of Research and Professor of Pathology, Dalhousie University
-
Associate Professor | Director, DNA Zoo Australia, The University of Western Australia
-
Professor of Medicine and Vice President, Research, McMaster University
-
Assistant Professor/Canada Research Chair in emerging viruses, University of Manitoba
-
Postdoctoral fellow, Australian National University
-
Junior Fellow, MacEachen Institute for Public Policy and Governance; Medical Student, Dalhousie University
-
Professor of English, York University, Canada
-
Honorary Fellow, Department of Pathology, The University of Melbourne
-
Research Scientist and Principal Investigator at the Vaccine and Infectious Disease Organization, University of Saskatchewan
